NCT03061825View on ClinicalTrials.gov

Zenith Alpha™ Abdominal Endovascular Graft

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 24, 2017

Primary Completion Date

January 6, 2021

Study Completion Date

January 6, 2021

Conditions
Abdominal AorticAorto-iliac Aneurysm
Interventions
DEVICE

Zenith Alpha™ Abdominal Endovascular Graft

Zenith Alpha™ Abdominal Endovascular Graft for the treatment of abdominal aortic or aorto-iliac aneurysm.

Trial Locations (5)

V6T 2B5

Vancouver Hospital and Health Science Center, Vancouver

B3H3A7

Nova Soctia Health Authority, Halifax

L8L2X2

Hamilton General Hospital, Hamilton

N6A 4G5

London Health Sciences Center, London

M5G 1X6

Toronto General Hospital, Toronto

All Listed Sponsors
lead

Cook Research Incorporated

INDUSTRY

NCT03061825 - Zenith Alpha™ Abdominal Endovascular Graft | Biotech Hunter | Biotech Hunter